76-90 of 813
Optimizing Generalized Myasthenia Gravis Care Through Patient-Centered Choices
NeuroFrontiersOptimizing Generalized Myasthenia Gravis Care Through Patient-Centered Choices
Sheetal Shroff, MD
Timing Meningococcal Vaccines in gMG: Challenges and Considerations
NeuroFrontiersTiming Meningococcal Vaccines in gMG: Challenges and Considerations
Michael Weiss, MD
Individualizing gMG Treatment: Defining Success With Each Patient
NeuroFrontiersIndividualizing gMG Treatment: Defining Success With Each Patient
Omar Sinno, MD
Linking Obesity to Alzheimer’s: The Lipid Signals Driving Neurodegeneration
Clinician's RoundtableLinking Obesity to Alzheimer’s: The Lipid Signals Driving Neurodegeneration
Stephen Wong, PhD
LUMINESCE: Assessing Satralizumab in Generalized Myasthenia Gravis
NeuroFrontiersLUMINESCE: Assessing Satralizumab in Generalized Myasthenia Gravis
Advancements in gMG Management: Zilucoplan as an Alternative to C5 Inhibitors
NeuroFrontiersAdvancements in gMG Management: Zilucoplan as an Alternative to C5 Inhibitors
- advertisement
Examining Inebilizumab in Generalized Myasthenia Gravis: Insights from MINT
NeuroFrontiersExamining Inebilizumab in Generalized Myasthenia Gravis: Insights from MINT
Ryan Quigley
Advancing MS Care: Diagnostic Clarity, Early Action, and Patient-Centered Treatment
On the Frontlines of Multiple SclerosisAdvancing MS Care: Diagnostic Clarity, Early Action, and Patient-Centered Treatment
Tirisham V. Gyang, MD
Gates B. Colbert, MD
Prevention on the Horizon: Early Intervention and Risk Reduction in MS Care
On the Frontlines of Multiple SclerosisPrevention on the Horizon: Early Intervention and Risk Reduction in MS Care
Vikram V. Bhise, MD
Evolving Diagnostic and Prognostic Strategies in Multiple Sclerosis Care
On the Frontlines of Multiple SclerosisEvolving Diagnostic and Prognostic Strategies in Multiple Sclerosis Care
Ashley Baker, MSN, PMHNP
Jay Avasarala, MD, PhD
Genetic Testing in Pediatrics: Identifying Neurodevelopmental Disorders Early
Clinician's RoundtableGenetic Testing in Pediatrics: Identifying Neurodevelopmental Disorders Early
Jennifer M. Kalish, MD, PhD, FAAP
Genetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant
NeuroFrontiersGenetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant
Sergio Baranzini, PhD
- advertisement
Understanding Antibody-Mediated Demyelinating Diseases: Key Differences From MS
NeuroFrontiersUnderstanding Antibody-Mediated Demyelinating Diseases: Key Differences From MS
Michael Levy, MD, PhD
Navigating MS Diagnosis in Older Adults: Distinguishing Comorbidities and Mimics
NeuroFrontiersNavigating MS Diagnosis in Older Adults: Distinguishing Comorbidities and Mimics
Le Hua, MD
Retinal Vein Occlusion as a Predictor of Stroke
Eye on Ocular HealthRetinal Vein Occlusion as a Predictor of Stroke
